Gene: PRDM12
Official Full Name: PR/SET domain 12provided by HGNC
Gene Summary: This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN's) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia. [provided by RefSeq, Mar 2017]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA01711 | PRDM12 Knockout cell line (293T) | Human | PRDM12 | 1:3~1:6 | negative | Online Inquiry |
| KOA07821 | PRDM12 Knockout cell line (AC16) | Human | PRDM12 | 1:3-1:4 | negative | Online Inquiry |
| KOA23267 | PRDM12 Knockout cell line (BEAS-2B) | Human | PRDM12 | 1:3~1:4 | negative | Online Inquiry |
| KOA38715 | PRDM12 Knockout cell line (U-2932) | Human | PRDM12 | 1:2-1:4 | negative | Online Inquiry |
| KOA54110 | PRDM12 Knockout cell line (TPC-1) | Human | PRDM12 | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.